Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator
Carmel M. Mcnicholas, William B. Guggino, Erik M. Schwiebert, Steven C. Hebert, Gerhard Giebisch, Marie E. Egan
Dive into the research topics of 'Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator'. Together they form a unique fingerprint.